2013
DOI: 10.1002/jgm.2723
|View full text |Cite
|
Sign up to set email alerts
|

PhiC31 integrase‐mediated genomic integration and stable gene expression in the mouse mammary gland after gene electrotransfer

Abstract: The results obtained in the present study show that the use of phiC31 integrase is a feasible and efficient method for high and stable transgene expression in the mouse mammary gland.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 47 publications
(73 reference statements)
0
1
0
Order By: Relevance
“…Even non‐integrated adeno‐associated recombinant viruses (rAAVs), which currently are the most attractive viral vectors, along with retro‐ and lentiviral vectors, have several serious disadvantages for use in gene therapy and even in gene functional studies, such as low cloning capacity and lack of long‐term transgene expression. Another method is based on integration of a gene into a “hot spot” of a mammalian genome using a bacteriophage P1‐derived Cre recombinase or ΦC31 integrase (Luo et al., 2013). However, efficiency of gene integration with such a system is very low.…”
Section: Commentarymentioning
confidence: 99%
“…Even non‐integrated adeno‐associated recombinant viruses (rAAVs), which currently are the most attractive viral vectors, along with retro‐ and lentiviral vectors, have several serious disadvantages for use in gene therapy and even in gene functional studies, such as low cloning capacity and lack of long‐term transgene expression. Another method is based on integration of a gene into a “hot spot” of a mammalian genome using a bacteriophage P1‐derived Cre recombinase or ΦC31 integrase (Luo et al., 2013). However, efficiency of gene integration with such a system is very low.…”
Section: Commentarymentioning
confidence: 99%